Comprehensive Geriatric Assessment - Can it Improve Quality of Life

Quality of Life Clinical Trial

Official title:

Comprehensive Geriatric Assessment - Can it Improve Quality of Life

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01925105
• Other study ID #: AFC-162
• Status: Active, not recruiting
• Phase: N/A
• First received: August 13, 2013
• Last updated: September 14, 2015
• Start date: August 2013
• Est. completion date: April 2016

Study information

• Verified date: September 2015
• Source: Örebro County Council
• Contact: n/a
• Is FDA regulated: No
• Health authority: Sweden: Regional Ethical Review Board
• Study type: Interventional

Clinical Trial Summary

Like most developed countries the population of Sweden is getting older and consequently the number of individuals with chronic diseases will be an increasing challenge for its healthcare system. To improve care of the frail elderly, wards with a coordinated multidisciplinary team and multidisciplinary mobile teams were established several years ago. Treatment and follow up is planned in accordance to the patients' medical, psychological and functional capabilities (Comprehensive Geriatric Assessment = CGA). There are to our knowledge only few studies concerning CGA applicable to Swedish conditions. We plan to conduct a Swedish study that evaluates if care and treatment with a modified CGA-model in an outpatient setting can improve quality of life for frail older people.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 220
• Est. completion date: April 2016
• Est. primary completion date: April 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Age =65 years

• Live in own home

• Reason to believe that the health condition is not optimal or could be optimized

• Meet at least 2/6 of the following criteria: cognitive impairment, general tiredness or dyspnea, have fallen often/afraid to fall, need help with activities of daily living, hospital care =3 times within the last 12 months, care problems at home

Exclusion Criteria:

• Psychosis

• Not understand the Swedish language

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Quality of Life

Intervention

Other:
• Experimental: Optimization of treatment
Optimization of treatment of diseases and symptoms

Locations

Country	Name	City	State
Sweden	Örebro County Council	Örebro

Sponsors (1)

Lead Sponsor	Collaborator
Örebro County Council

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	The quality of drug treatment		1 year from baseline	No
Primary	Retained or increased quality of life of at least 20% measured by EQ-5D (EuroQOL) after 1 year from baseline.		1 year from baseline	No
Secondary	Readmission to hospital		1 year from baseline	No